Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

60

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial

Tags:

Previous Article

Timescapes of non-human experience

Parkinson's medication shows promise in treating depression

Related Posts

Laminar organization of pyramidal neuron cell types defines distinct CA1 hippocampal subregions

Laminar organization of pyramidal neuron cell types def...

66

Molecular architecture of human dermal sleeping nociceptors

Molecular architecture of human dermal sleeping nocicep...

67

Structural modeling reveals the mechanism of motor ATPase coordination during type IV pilus retraction

Structural modeling reveals the mechanism of motor ATPa...

58